RGS
Click for more information
0.00% 12.0¢ regeneus ltd

RGSH4K is also undergoing pre-clinical trials with an anti-pd1...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. phillip_k
    4,884 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    30/07/18
    11:16
    Post #: 34621484
    RGSH4K is also undergoing pre-clinical trials with an anti-pd1 inhibitor for combination therapy.These results should be available in the near future too.
    RGS Price at posting: 23.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.